Viromers as carriers for mRNA-mediated expression of therapeutic molecules under inflammatory conditions

Sci Rep. 2020 Sep 15;10(1):15090. doi: 10.1038/s41598-020-72004-8.

Abstract

Therapeutic mRNA delivery has been described for several treatment options, such as vaccination and cancer immunotherapy. However, mRNA delivery has to be accompanied by the development and testing of suitable carrier materials due to the instability of mRNAs in human body fluids. In the present study, we investigated the ability of recently developed Viromers to deliver mRNAs in a classical inflammatory setting. We tested mRNAs coding for active components of preclinical (7ND) and approved (sTNF-RII) biologics, in vitro and in vivo. 7ND is an established blocker of the CCR2 axis, whereas sTNF-RII is the active component of the approved drug Etanercept. Viromer/mRNA complexes were transfected into murine macrophages in vitro. Protein expression was analysed using Luciferase reporter expression and mainly identified in spleen, blood and bone marrow in vivo. 7ND-mRNA delivery led to efficient blockage of monocytes infiltration in thioglycolate-induced peritonitis in mice, underlining the ability of Viromers to deliver a therapeutic mRNA cargo without overt toxicity. Therefore, we propose Viromer-based mRNA delivery as a suitable option for the treatment of inflammatory disorders beyond infusion of biological molecules.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Line
  • Drug Carriers / chemistry*
  • Female
  • Inflammation / metabolism*
  • Macrophages / metabolism
  • Male
  • Mice
  • Mice, Hairless
  • Mice, Inbred DBA
  • Monocytes / metabolism
  • Polyethyleneimine / chemistry
  • Polymers / chemistry*
  • RAW 264.7 Cells
  • RNA, Messenger / chemistry*
  • RNA, Messenger / metabolism*
  • Receptors, CCR2 / metabolism
  • Receptors, Tumor Necrosis Factor, Type II / metabolism

Substances

  • Drug Carriers
  • Polymers
  • RNA, Messenger
  • Receptors, CCR2
  • Receptors, Tumor Necrosis Factor, Type II
  • Polyethyleneimine